Form D · Other Health Care

IMRIS Inc.

Winnipeg, A2 · CIK 0001489161

Offering snapshot reported Sep 25, 2013 · SEC filing

Reported sold
$36.8M
Offering amount: $36.8M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 16, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2013Initial$36,834,000No comparison4SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1M
Finders' fees
$0
Form D file number
021-203546
Common Stock, Notes, Warrants and underlying Common Stock

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cowen and Company7616

Source: Form D, filed Sep 25, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Armstrong Director
Amy Boyle Executive
Robert Burgess Director
Meir Dahan Executive
Carey Diamond Director
William Fraser Director
Mike Fritts Executive
H. David Graves Director
James B. Hickey, Jr. Director
Blaine Hobson Director
Maurice Holloman Executive
Kelly Mc Neill Executive
Jay Miller Director, Executive
Mark Reade Executive
Denis Sutton Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
100 1370 Sony Place
Winnipeg, A2, R3T 1N5